Journal of Affective Disorders 2000: Vol 61 Index

7 Pages·2000·1.9 MB·English

JOURNAL OF
AFFECTIVE
DISORDERS
Journal of Affective Disorders 61 (2000) 257-258
www.elsevier.com/locate/jad
Author index
Abajian, H., see Feighner, J.P. (61) 119 A double-blind, placebo-controlled, efficacy, safety, and phar-
Alda, M., see Grof, P. (61) 31 macokinetic study of INN 00835, a novel antidepressant
peptide, in the treatment of major depression (61) 119
Baker, G.B., see Sherry, R.L. (61) 23 Fermanian, J., see Guedeney, N. (61) 107
Baldessarini, R.J., Tondo, L., Floris, G. and Hennen, J. Fleck, D.E., see Strakowski, S.M. (61) 87
Effects of rapid cycling on response to lithium maintenance Floris, G., see Baldessarini, R.J. (61) 13
treatment in 360 bipolar I and II disorder patients (61) 13 Fowles, D.C.
Barefoot, J.C., see Brummett, B.H. (61) 41 Electrodermal hyporeactivity and antisocial behavior: does
Barlow, D., see Van den Hout, M. (61) 241 anxiety mediate the relationship? (61) 177
Beekman, A.T.F., see Penninx, B.W.J.H. (61) | Friberg, T.R. and Borrero, G.
Benazzi, F. Diminished perception of ambient light: a symptom of clinical
Early-onset versus late-onset atypical depression: unipolar and depression? (61) 113
bipolar II (61) 95
Berghoefer, A., see Grof, P. (61) 31 Glaudin, V., see Londborg, P.D. (61) 73
Borrero, G., see Friberg, T.R. (61) 113 Gorman, J.M., see Sinha, S. (61) 191
Bourne, M.L., see Strakowski, S.M. (61) 87 Gray, J.A., see McNaughton, N. (61) 161
Brummett, B.H., Barefoot, J.C., Siegler, 1.C. and Steffens, D.C. Grof, P., Robbins, W., Alda, M., Berghoefer, A., Vojtechovsky, M.,
Relation of subjective and received social support to clinical Nilsson, A. and Robertson, C.
and self-report assessments of depressive symptoms in an Protective effect of pregnancy in women with lithium-respon-
elderly population (61) 41 sive bipolar disorder (61) 31
Guedeney, N., Fermanian, J., Guelfi, J.D. and Kumar, R.C.
Camardese, G., see Sarchiapone, M. (61) 69 The Edinburgh Postnatal Depression Scale (EPDS) and the
Cardascia, L., see Preti, A. (61) 101 detection of major depressive disorders in early postpartum:
Carter, J.D., Joyce, P.R., Mulder, R.T., Luty, S.E. and McKenzie, some concerns about false negatives (61) 107
k. Guelfi, J.D., see Guedeney, N. (61) 107
Gender differences in the presentation of depressed outpati- Guralnik, J.M., see Penninx, B.W.J.H. (61) |
ents: a comparison of descriptive variables (61) 59
Cooke, R.G., see Kusznir, A. (61) 81 Hennen, J., see Baldessarini, R.J. (61) 13
Coutts, R.T., see Sherry, R.L. (61) 23 Hlavka, J., see Feighner, J.P. (61) 119
Hoehn-Saric, R. and McLeod, D.R.
Davis, M., see Lang, P.J. (61) 137 Anxiety and arousal: physiological changes and their percep-
Deeg, D.J.H., see Penninx, B.W.J.H. (61) | tion (61) 217
DelBello, M.P., see Strakowski, S.M. (61) 87
Denda, K., see Izumi, T. (61) 127 Inoue, T., see Izumi, T. (61) 127
De Risio, S., see Sarchiapone, M. (61) 69 Izumi, T., Inoue, T., Kitagawa, N., Nishi, N., Shimanaka, S.,
Takahashi, Y., Kusumi, I., Odagaki, Y., Denda, K., Ohmori, T.
Ehrensing, R.H., see Feighner, J.P. (61) 119 and Koyama, T.
Eiring, A., see Manier, D.H. (61) 51 Open pergolide treatment of tricyclic and heterocyclic antide-
Ellis, T.C., see Manier, D.H. (61) 51 pressant-resistant depression (61) 127
Favaretto, G., see Preti, A. (61) 101 Joyce, P.R., see Carter, J.D. (61) 59
Feighner, J.P., Ehrensing, R.H., Kastin, A.J., Leonard, B.E.,
Sverdlov, L., Nicolau, G., Patel, A., Hlavka, J., Abajian, H. Kastin, A.J., see Feighner, J.P. (61) 119
and Noble, J.F. Kitagawa, N., see Izumi, T. (61) 127
$0165-0327(00)00376-1
258 Author index
Koyama, T., see Izumi, T. (61) 127 Preti, A., Cardascia, L., Zen, T., Pellizzari, P., Marchetti, M.,
Kumar, R.C., see Guedeney, N. (61) 107 Favaretto, G. and Miotto, P.
Kusumi, I., see Izumi, T. (61) 127 Obstetric complications in patients with depression — a
Kusznir, A., Cooke, R.G. and Young, L.T. population-based case—control study (61) 101
The correlates of community functioning in patients with
bipolar disorder (61) 81 Rauw, G., see Sherry, R.L. (61) 23
Robbins, W., see Grof, P. (61) 31
Lane, R.D., see Thayer, J.F. (61) 201 Robertson, C., see Grof, P. (61) 31
Lang, P. and Maser, J.D.
Roth, W.T., see Orr, S.P. (61) 225
Editorial (61) 133 Roy, A., see Sarchiapone, M. (61) 69
Lang, P.J., Davis, M. and Ohman, A.
Fear and anxiety: animal models and human cognitive psycho-
Sarchiapone, M., Roy, A., Camardese, G. and De Risio, S.
physiology (61) 137
Further evidence for low serum cholesterol and_ suicidal
Leonard, B.E., see Feighner, J.P. (61) 119
behaviour (61) 69
Londborg, P.D., Smith, W.T., Glaudin, V. and Painter, J.R.
Sax, K.W., see Strakowski, S.M. (61) 87
Short-term cotherapy with clonazepam and fluoxetine: anxiety,
Shelton, R.C., see Manier, D.H. (61) 51
sleep disturbance and core symptoms of depression (61) 73
Sherry, R.L., Rauw, G., McKenna, K.F., Paetsch, P.R., Coutts,
Luty, S.E., see Carter, J.D. (61) 59
R.T. and Baker, G.B.
Failure to detect amphetamine or |-amino-3-phenlypropane in
Manier, D.H., Shelton, R.C., Ellis, T.C., Peterson, C.S., Eiring, A.
humans or rats receiving the MAO inhibitor tranylcypromine
and Sulser, F.
(61) 23
Human fibroblasts as a relevant model to study signal trans-
Shimanaka, S., see Izumi, T. (61) 127
duction in affective disorders (61) 51
Siegler, I.C., see Brummett, B.H. (61) 41
Marchetti, M., see Preti, A. (61) 101
Sinha, S., Papp, L.A. and Gorman, J.M.
Maser, J.D., see Lang, P. (61) 133
How study of respiratory physiology aided our understanding
McKenna, K.F., see Sherry, R.L. (61) 23
of abnormal brain function in panic disorder (61) 191
McKenzie, J., see Carter, J.D. (61) 59
Smith, W.T., see Londborg, P.D. (61) 73
McLeod, D.R., see Hoehn-Saric, R. (61) 217
Steffens, D.C., see Brummett, B.H. (61) 41
McNaughton, N. and Gray, J.A.
Strakowski, S.M., Williams, J.R., Sax, K.W., Fleck, D.E.,
Anxiolytic action on the behavioural inhibition system implies
DelBello, M.P. and Bourne, M.L.
multiple types of arousal contribute to anxiety (61) 161
Is impaired outcome following a first manic episode due to
Miotto, P., see Preti, A. (61) 101
Mulder, R.T., see Carter, J.D. (61) 59 mood-incongruent psychosis? (61) 87
Sulser, F., see Manier, D.H. (61) 51
Nicolau, G., see Feighner, J.P. (61) 119 Sverdlov, L., see Feighner, J.P. (61) 119
Nilsson, A., see Grof, P. (61) 31
Nishi, N., see Izumi, T. (61) 127 Takahashi, Y., see Izumi, T. (61) 127
Noble, J.F., see Feighner, J.P. (61) 119 Thayer, J.F. and Lane, R.D.
A model of neurovisceral integration in emotion regulation
Odagaki, Y., see Izumi, T. (61) 127 and dysregulation (61) 201
Ohman, A., see Lang, P.J. (61) 137 Tondo, L., see Baldessarini, R.J. (61) 13
Ohmori, T., see Izumi, T. (61) 127
Orr, S.P. and Roth, W.T. van den Hout, M. and Barlow, D.
Psychophysiological assessment: clinical applications for Attention, arousal and expectancies in anxiety and sexual
PTSD (61) 225 disorders (61) 241
van Eijk, J.Th.M., see Penninx, B.W.J.H. (61) 1
Paetsch, P.R., see Sherry, R.L. (61) 23 Vojtechovsky, M., see Grof, P. (61) 31
Painter, J.R., see Londborg, P.D. (61) 73
Papp, L.A., see Sinha, S. (61) 191 Williams, J.R., see Strakowski, S.M. (61) 87
Patel, A., see Feighner, J.P. (61) 119
Pellizzari, P., see Preti, A. (61) 101 Young, L.T., see Kusznir, A. (61) 81
Penninx, B.W.J.H., Deeg, D.J.H., van Eijk, J.Th.M., Beekman,
A.T.F. and Guralnik, J.M. Zen, T., see Preti, A. (61) 101
Changes in depression and physical decline in older adults: a
longitudinal perspective (61) 1
Peterson, C.S., see Manier, D.H. (61) 51
AFJFOUERNCATL IVOF E
DISORDERS
Journal of Affective Disorders 61 (2000) 259-261
www.elsevier.com/locate/jad
Subject index
1-Amino-3-phenylpropane; Amphetamine; Electron-capture gas Assessment; Post-traumatic stress disorder; Psychophysiological
chromatography; Metabolism; Pentafluorobenzenesulfonyl chlo- findings; Clinical application 61, 225
ride; Tranylcypromine 61, 23
Atypical; Depression; Bipolar 61, 95
Amphetamine; |-Amino-3-phenylpropane; Electron-capture gas
Augmentation; Clonazepam; Cotherapy; Fluoxetine; Major de-
chromatography; Metabolism; Pentafluorobenzenesulfonyl chlo-
pression; Side-effects (drug); Drug therapy 61, 73
ride; Tranylcypromine 61, 23
Behavioral inhibition system; Psychopathy; Electrodermal; Skin
Animal models; Fear; Anxiety; Startle-reflex; Psychophysiology; conductance; Impulsivity; Anxiety 61, 177
Defense motivation 61, 137
Behavioural inhibition system; Anxiety; Arousal; Generalized
Antidepressants; Peptides; Serotonin 61, 119 anxiety disorder; Anxiolytic; Septo-hippocampal system; Hip-
pocampus; Theta activity; Theta rhythm 61, 161
Anxiety; Pregnancy; Bipolar disorder; Placenta; Postpartum de-
pression 61, 31 Beta adrenoceptors; Human fibroblasts; Major depression;
Cyclic AMP; Isoproterenol; Protein kinase A (PKA); CREB-P;
Anxiety; Human fibroblasts; Beta adrenoceptors; Cyclic AMP;
Luciferase activity 61, 51
Isoproterenol; Protein kinase A (PKA); CREB-P; Luciferase
activity 61, 51 Biopolar disorder; Mood-incongruent psychosis; DSM-IV;
Schizoaffactive disorder 61, 87
Anxiety; Gender; Symptomatology; Characteristics 61, 59
Bipolar; Depression; Atypical 61, 95
Anxiety; Clonazepam; Cotherapy; Fluoxetine; Side-effects (drug);
Drug therapy; Augmentation 61, 73 Bipolar disorder; Pregnancy; Placenta; Lithium; Postpartum
depression 61, 31
Anxiety; Community functioning; Comorbid alcohol abuse 61, 81
Bipolar I and II disorders; Illness course; Lithium; Rapid
Anxiety; Atypical; Bipolar 61, 95
cycling 61, 13
Anxiety; Brain damage; Gestational; obstetric complications 61,
Brain damage; Depression; Gestational; obstetric complications
101
61, 101
Anxiety; Arousal; Generalized anxiety disorder; Behavioural
Characteristics; Depression; Gender; Symptomatology 61, 59
inhibition system; Anxiolytic; Septo-hippocampal system; Hip-
pocampus; Theta activity; Theta rhythm 61, 161 Clinical application; Post-traumatic stress disorder; Psycho-
physiological findings; Assessment 61, 225
Anxiety; Psychopathy; Electrodermal; Skin conductance; Be-
havioral inhibition system; Impulsivity 61, 177 Clonazepam; Cotherapy; Fluoxetine; Major depression; Side-
effects (drug); Drug therapy; Augmentation 61, 73
Anxiety; Sexual disorder; Dysfunctional; Selective attention 61,
241 Community functioning; Bipolar disorder; Comorbid alcohol
abuse 61, 81
Anxiety; Fear; Startle-reflex; Psychophysiology; Animal models;
Defense motivation 61, 137 Comorbid alcohol abuse; Bipolar disorder; Community func-
tioning 61, 81
Anxiolytic; Anxiety; Arousal; Generalized anxiety disorder; Be-
havioural inhibition system; Septo-hippocampal system; Hip- Cotherapy; Clonazepam; Fluoxetine; Major depression; Side-
pocampus; Theta activity; Theta rhythm 61, 161 effects (drug); Drug therapy; Augmentation 61, 73
Arousal; Anxiety; Generalized anxiety disorder; Behavioural CREB-P; Human fibroblasts; Major depression; Beta adreno-
inhibition system; Anxiolytic; Septo-hippocampal system; Hip- ceptors; Cyclic AMP; Isoproterenol; Protein kinase A (PKA);
pocampus; Theta activity; Theta rhythm 61, 161 Luciferase activity 61, 51
$0165-0327(00)00377-7
260 Subject index
Cyclic AMP; Human fibroblasts; Major depression; Beta adreno- Human fibroblasts; Major depression; Beta adrenoceptors;
ceptors; Isoproterenol; Protein kinase A (PKA); CREB-P; Lucifer- Cyclic AMP; Isoproterenol; Protein kinase A (PKA); CREB-P;
ase activity 61, 51 Luciferase activity 61, 51]
Defense motivation; Fear; Anxiety; Startle-reflex; Psycho- Hyperventilation; Respiration physiology; Panic attacks 61, 191
physiology; Animal models 61, 137
Illness course; Bipolar I and II disorders; Lithium; Rapid cycling
Depression; Physical decline; Older adults 61, | 61, 13
Depressive symptoms; Subjective social support; Received social Impulsivity; Psychopathy; Electrodermal; Skin conductance; Be-
support 61, 41 havioral inhibition system; Anxiety 61, 177
Dim light; Perception of light; Major depression 61, 113 Isoproterenol; Human fibroblasts; Major depression; Beta ad-
renoceptors; Cyclic AMP; Protein kinase A (PKA); CREB-P;
Disorder; Physiological flexibility; Perception of somatic symp-
Luciferase activity 61, 51
toms; Generalized anxiety; Panic disorder; Obsessive-compulsive
disorder; Somatic symptoms 61, 217 Lithium; Bipolar I and II disorders; Illness course; Rapid cycling
61, 13
Dopamine; Pergolide; Refractory depression; Treatment-resistant
depression 61, 127 Luciferase activity; Human fibroblasts; Major depression; Beta
adrenoceptors; Cyclic AMP; Isoproterenol; Protein kinase A
Drug therapy; Clonazepam; Cotherapy; Fluoxetine; Major de-
pression; Side-effects (drug); Augmentation 61, 73 (PKA); CREB-P 61, 51
DSM-IV; Mood-incongruent psychosis; Biopolar disorder; Major depression; Perception of light; Dim light 61, 113
Schizoaffactive disorder 61, 87
Metabolism; |-Amino-3-phenylpropane; Amphetamine; Electron-
Dysfunctional; Anxiety; Sexual disorder; Selective attention 61, capture gas chromatography; Pentafluorobenzenesulfony! chloride;
241 Tranylcypromine 61, 23
Electrodermal; Psychopathy; Skin conductance; Behavioral inhi- Mood-incongruent psychosis; Biopolar disorder; DSM-IV;
bition system; Impulsivity; Anxiety 61, 177 Schizoaffactive disorder 61, 87
Electron-capture gas chromatography; 1-Amino-3- Neurovisceral integration; Emotion regulation and dysregulation
phenylpropane; Amphetamine; Metabolism; Pentafluoroben- 61, 201
zenesulfonyl chloride; Tranylcypromine 61, 23
Obsessive-compulsive disorder; Physiological flexibility; Percep-
Emotion regulation and dysregulation; Neurovisceral integra- tion of somatic symptoms; Generalized anxiety; Disorder; Panic
tion 61, 201 disorder; Somatic symptoms 61, 217
EPDS; Post natal depression; False negative; Psychomotor re- obstetric complications; Brain damage; Depression; Gestational
tardation 61, 107 61, 101
False negative; Post natal depression; EPDS; Psychomotor re- Older adults; Depression; Physical decline 61, |
tardation 61, 107
Panic attacks; Respiration physiology; Hyperventilation 61, 191
Fear; Anxiety; Startle-reflex; Psychophysiology; Animal models;
Panic disorder; Physiological flexibility; Perception of somatic
Defense motivation 61, 137
symptoms; Generalized anxiety; Disorder; Obsessive-compulsive
Fluoxetine; Clonazepam; Cotherapy; Major depression; Side-ef- disorder; Somatic symptoms 61, 217
fects (drug); Drug therapy; Augmentation 61, 73
Pentafluorobenzenesulfonyl chloride; 1-Amino-3-
Gender; Depression; Symptomatology; Characteristics 61, 59 phenylpropane; Amphetamine; Electron-capture gas chromatog-
raphy; Metabolism; Tranylcypromine 61, 23
Generalized anxiety disorder; Anxiety; Arousal; Behavioural
inhibition system; Anxiolytic; Septo-hippocampal system; Hip- Peptides; Antidepressants; Serotonin 61, 119
pocampus; Theta activity; Theta rhythm 61, 161
Perception of light; Dim light; Major depression 61, 113
Generalized anxiety; Physiological flexibility; Perception of
Perception of somatic symptoms; Physiological flexibility;
somatic symptoms; Disorder; Panic disorder; Obsessive-compul-
Generalized anxiety; Disorder; Panic disorder; Obsessive-compul-
sive disorder; Somatic symptoms 61, 217
sive disorder; Somatic symptoms 61, 217
Gestational; Brain damage; Depression; obstetric complications
Pergolide; Dopamine; Refractory depression; Treatment-resistant
61, 101
depression 61, 127
Hippocampus; Anxiety; Arousal; Generalized anxiety disorder;
Physical decline; Depression; Older adults 61, |
Behavioural inhibition system; Anxiolytic; Septo-hippocampal
system; Theta activity; Theta rhythm 61, 161 Physiological flexibility; Perception of somatic symptoms;
Subject index 261
Generalized anxiety; Disorder; Panic disorder; Obsessive-compul- Selective attention; Anxiety; Sexual disorder; Dysfunctional 61,
sive disorder; Somatic symptoms 61, 217 241
Placenta; Pregnancy; Bipolar disorder; Lithium; Postpartum Septo-hippocampal system; Anxiety; Arousal; Generalized anxi-
depression 61, 31 ety disorder; Behavioural inhibition system; Anxiolytic; Hip-
pocampus; Theta activity; Theta rhythm 61, 161
Post natal depression; EPDS; False negative; Psychomotor
retardation 61, 107 Serotonin; Antidepressants; Peptides 61, 119
Postpartum depression; Pregnancy; Bipolar disorder; Placenta; Serum cholesterol; Suicidal behavior; Relationship 61, 69
Lithium 61, 31
Sexual disorder; Anxiety; Dysfunctional; Selective attention 61,
Post-traumatic stress disorder; Psychophysiological findings; 241
Clinical application; Assessment 61, 225
Side-effects (drug); Clonazepam; Cotherapy; Fluoxetine; Major
Pregnancy; Bipolar disorder; Placenta; Lithium; Postpartum
depression; Drug therapy; Augmentation 61, 73
depression 61, 31
Skin conductance; Psychopathy; Electrodermal; Behavioral inhi-
Protein kinase A (PKA); Human fibroblasts; Major depression;
bition system; Impulsivity; Anxiety 61, 177
Beta adrenoceptors; Cyclic AMP; Isoproterenol; CREB-P;
Luciferase activity 61, 51 Somatic symptoms; Physiological flexibility; Perception of
somatic symptoms; Generalized anxiety; Disorder; Panic disorder;
Psychomotor retardation; Post natal depression; EPDS; False
Obsessive-compulsive disorder 61, 217
negative 61, 107
Startle-reflex; Fear; Anxiety; Psychophysiology; Animal models;
Psychopathy; Electrodermal; Skin conductance; Behavioral inhi-
Defense motivation 61, 137
bition system; Impulsivity; Anxiety 61, 177
Subjective social support; Depressive symptoms; Received
Psychophysiological findings; Post-traumatic stress disorder;
social support 61, 41
Clinical application; Assessment 61, 225
Suicidal behavior; Serum cholesterol; Relationship 61, 69
Psychophysiology; Fear; Anxiety; Startle-reflex; Animal models;
Defense motivation 61, 137 Symptomatology; Depression; Gender; Characteristics 61, 59
Rapid cycling; Bipolar I and II disorders; IIIness course; Lithium Theta activity; Anxiety; Arousal; Generalized anxiety disorder;
61, 13 Behavioural inhibition system; Anxiolytic; Septo-hippocampal
system; Hippocampus; Theta rhythm 61, 161
Received social support; Depressive symptoms; Subjective social
support 61, 41 Theta rhythm; Anxiety; Arousal; Generalized anxiety disorder;
Behavioural inhibition system; Anxiolytic; Septo-hippocampal
Refractory depression; Pergolide; Dopamine; Treatment-resistant
system; Hippocampus; Theta activity 61, 161
depression 61, 127
Tranylcypromine; 1|-Amino-3-phenylpropane; Amphetamine;
Relationship; Serum cholesterol; Suicidal behavior 61, 69
Electron-capture gas chromatography; Metabolism; Pentafluoro-
Respiration physiology; Hyperventilation; Panic attacks 61, 191 benzenesulfony! chloride 61, 23
Schizoaffactive disorder; Mood-incongruent psychosis; Biopolar Treatment-resistant depression; Pergolide; Dopamine; Refract-
disorder; DSM-IV 61, 87 ory depression 61, 127